DNA X, Inc. (SONM) |
| 3.46 0.19 (5.81%) 08-28 16:00 |
| Open: | 3.48 |
| High: | 3.5 |
| Low: | 3.35 |
| Volume: | 9,750 |
| Market Cap: | 5(M) |
| PE Ratio: | -0.12 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Communication Equipment |
| Sector: | Technology |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 4.30 |
| Resistance 1: | 3.77 |
| Pivot price: | 3.37 |
| Support 1: | 2.92 |
| Support 2: | 2.43 |
| 52w High: | 16.974 |
| 52w Low: | 2.521 |
DNA X, Inc., formerly known as Sonim Technologies, Inc. until its rebranding in January 2026, is a company established in 1999 and headquartered in San Diego, California. The firm specializes in delivering enterprise-grade 5G solutions across a broad international footprint, encompassing the United States, Canada, Europe, the Middle East, and the Asia-Pacific region. Their product portfolio includes a comprehensive range of ruggedized communication devices tailored for frontline and task workers. This lineup features models such as the Sonim XP10, Sonim XP5plus, Sonim XP3plus, Sonim XP Pro, as well as the XP100 4G and XP400 5G professional rugged phones, XP Pro 5G rugged smartphones, and XP3plus 5G rugged flip phones. Beyond handsets, DNA X, Inc. also provides connected solutions, offering both fixed wireless access and mobile hotspot devices. These include the Sonim H100 low- and mid-range mobile hotspots, the Sonim H700, and the advanced Sonim H500-series of 5G mobile hotspots. Complementing its hardware offerings, the company supplies proprietary SonimWare software and a selection of industrial-grade accessories. DNA X, Inc. distributes its products through a diverse network that includes wireless carriers, data device distributors, communications system integrators, and electronics resellers. The company's clientele spans various critical industries, including transportation and logistics, construction, manufacturing, facilities management, energy and utilities, mining, federal government agencies, and public safety organizations.
| EPS | -11.150 |
| Book Value | -0.780 |
| PEG Ratio | 0.25 |
| Gross Profit | -0.567 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 24.13 |
| Return on Assets (ttm) | -8.3 |
| Return on Equity (ttm) | 0.0 |
Thu, 27 Aug 2026
DNA awards Substitute Cash Grants to board including CEO Mike Mulica - TradingView
Thu, 27 Aug 2026
DNA X (SONM) turns to cash after equity plan runs out of shares - Stock Titan
Wed, 19 Aug 2026
DNA X, Inc. 2Q 2026: Revenue $0 EPS $(0.92) — 10-Q Summary - TradingView
Wed, 19 Aug 2026
DNA X: Q2 Earnings Snapshot - 10TV
Wed, 19 Aug 2026
DNA X, Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
Wed, 19 Aug 2026
Press Release: DNA X, Inc. Reports Second Quarter 2026 Financial Results - 富途牛牛
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |